Anteilseigner
SUNU Ventures BV (8,67 %) The Vanguard Group, Inc. (7,66 %) BlackRock Fund Advisors (5,58 %) Millennium Management LLC (3,63 %) Morningside Group Ltd. (3,40 %) SSgA Funds Management, Inc. (3,03 %) Morgan Stanley & Co. LLC (2,90 %) Goldman Sachs & Co. LLC (Private Banking) (2,74 %) Franklin Advisers, Inc. (2,73 %) Boxer Capital LLC (2,21 %) Two Sigma Investments LP (2,11 %) Citadel Advisors LLC (1,91 %) Farallon Capital Management LLC (1,69 %) Geode Capital Management LLC (1,57 %) Deerfield Management Co. LP (Private Equity) (1,54 %) D. E. Shaw & Co. LP (1,53 %) Goldman Sachs Asset Management LP (1,53 %)
Kontakt
AMYLYX PHARMACEUTICALS INC